PubMed:30973282
Annnotations
sonoma2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 0-6 | GENE | denotes | TIMP-1 |
| T1 | 7-15 | REG | denotes | Mediates |
| T2 | 16-28 | CPA | denotes | Inflammatory |
| T3 | 33-48 | CPA | denotes | Immune Response |
| T4 | 52-56 | GENE | denotes | IL-6 |
| T5 | 66-101 | DISEASE | denotes | Orbital Xanthogranulomatous Disease |
| T6 | 127-139 | MPA | denotes | pathogenesis |
| T7 | 145-151 | GENE | denotes | TIMP-1 |
| T8 | 152-160 | REG | denotes | mediated |
| T9 | 164-205 | DISEASE | denotes | adult orbital xanthogranulomatous disease |
| T10 | 170-205 | DISEASE | denotes | orbital xanthogranulomatous disease |
| T11 | 207-212 | DISEASE | denotes | AOXGD |
| T12 | 230-258 | DISEASE | denotes | non-Langerhans histiocytosis |
| T13 | 264-271 | NEGREG | denotes | damages |
| T14 | 276-286 | CPA | denotes | appearance |
| T15 | 302-306 | CPA | denotes | life |
| T16 | 366-371 | DISEASE | denotes | AOXGD |
| T17 | 458-468 | MPA | denotes | expression |
| T18 | 472-478 | GENE | denotes | TIMP-1 |
| T19 | 473-479 | GENE | denotes | IMP-1 |
| T20 | 483-487 | GENE | denotes | IL-6 |
| T21 | 484-488 | GENE | denotes | L-6 |
| T22 | 510-515 | DISEASE | denotes | AOXGD |
| T23 | 551-559 | REG | denotes | involved |
| T24 | 567-576 | POSREG | denotes | induction |
| T25 | 580-586 | GENE | denotes | TIMP-1 |
| T26 | 581-587 | GENE | denotes | IMP-1 |
| T27 | 591-595 | GENE | denotes | L-6. |
| T28 | 604-608 | GENE | denotes | IL-6 |
| T29 | 606-610 | GENE | denotes | -6 a |
| T30 | 613-619 | GENE | denotes | TIMP-1 |
| T31 | 615-621 | GENE | denotes | MP-1 w |
| T32 | 639-648 | POSREG | denotes | increased |
| T33 | 652-657 | DISEASE | denotes | AOXGD |
| T34 | 669-673 | GENE | denotes | -6 p |
| T35 | 672-680 | POSREG | denotes | promoted |
| T36 | 683-689 | GENE | denotes | MP-1 p |
| T37 | 688-698 | MPA | denotes | production |
| T38 | 720-731 | POSREG | denotes | stimulating |
| T39 | 736-751 | MPA | denotes | phosphorylation |
| T40 | 755-759 | GENE | denotes | JAK2 |
| T41 | 757-761 | GENE | denotes | K2 a |
| T42 | 766-771 | GENE | denotes | AT3. |
| T43 | 781-786 | GENE | denotes | IL-17 |
| T44 | 783-788 | GENE | denotes | -17 a |
| T45 | 793-802 | GENE | denotes | N-γ, the |
| T46 | 812-819 | MPA | denotes | markers |
| T47 | 823-826 | CPA | denotes | Th1 |
| T48 | 829-832 | GENE | denotes | d T |
| T49 | 831-841 | CPA | denotes | Th17 cells |
| T50 | 848-857 | POSREG | denotes | increased |
| T51 | 890-897 | REG | denotes | implied |
| T52 | 907-947 | PATHWAY | denotes | IL6~JAK2/STAT3-TIMP-1 signalling pathway |
| T53 | 914-935 | GENE | denotes | 2/STAT3-TIMP-1 signal |
| T54 | 951-960 | POSREG | denotes | activated |
| T55 | 964-969 | DISEASE | denotes | AOXGD |
| T56 | 995-998 | GENE | denotes | Th |
| T57 | 996-1010 | CPA | denotes | Th17 responses |
| T58 | 1015-1023 | REG | denotes | involved |
| T59 | 1046-1051 | DISEASE | denotes | AOXGD |
| R18 | T14 | T13 | ThemeOf | appearance,damages |
| R19 | T15 | T13 | ThemeOf | life,damages |
| R20 | T16 | T23 | ThemeOf | AOXGD,involved |
| R21 | T17 | T23 | ThemeOf | expression,involved |
| R22 | T17 | T24 | ThemeOf | expression,induction |
| R23 | T18 | T17 | ThemeOf | TIMP-1,expression |
| R24 | T18 | T23 | ThemeOf | TIMP-1,involved |
| R0 | T0 | T1 | ThemeOf | TIMP-1,Mediates |
| R1 | T2 | T1 | ThemeOf | Inflammatory,Mediates |
| R2 | T3 | T1 | ThemeOf | Immune Response,Mediates |
| R3 | T5 | T1 | ThemeOf | Orbital Xanthogranulomatous Disease,Mediates |
| R4 | T5 | T3 | ThemeOf | Orbital Xanthogranulomatous Disease,Immune Response |
| R5 | T6 | T8 | ThemeOf | pathogenesis,mediated |
| R6 | T7 | T6 | ThemeOf | TIMP-1,pathogenesis |
| R7 | T7 | T8 | ThemeOf | TIMP-1,mediated |
| R8 | T7 | T17 | ThemeOf | TIMP-1,expression |
| R9 | T9 | T6 | ThemeOf | adult orbital xanthogranulomatous disease,pathogenesis |
| R10 | T9 | T8 | ThemeOf | adult orbital xanthogranulomatous disease,mediated |
| R11 | T9 | T13 | ThemeOf | adult orbital xanthogranulomatous disease,damages |
| R12 | T11 | T6 | ThemeOf | AOXGD,pathogenesis |
| R13 | T11 | T8 | ThemeOf | AOXGD,mediated |
| R14 | T11 | T13 | ThemeOf | AOXGD,damages |
| R15 | T12 | T6 | ThemeOf | non-Langerhans histiocytosis,pathogenesis |
| R16 | T12 | T8 | ThemeOf | non-Langerhans histiocytosis,mediated |
| R17 | T12 | T13 | CauseOf | non-Langerhans histiocytosis,damages |
| R25 | T20 | T17 | ThemeOf | IL-6,expression |
| R26 | T20 | T23 | ThemeOf | IL-6,involved |
| R27 | T22 | T17 | ThemeOf | AOXGD,expression |
| R28 | T22 | T23 | ThemeOf | AOXGD,involved |
| R29 | T22 | T24 | ThemeOf | AOXGD,induction |
| R30 | T24 | T13 | CauseOf | induction,damages |
| R31 | T24 | T23 | CauseOf | induction,involved |
| R32 | T25 | T17 | ThemeOf | TIMP-1,expression |
| R33 | T25 | T23 | ThemeOf | TIMP-1,involved |
| R34 | T25 | T24 | ThemeOf | TIMP-1,induction |
| R35 | T28 | T32 | ThemeOf | IL-6,increased |
| R36 | T30 | T32 | ThemeOf | TIMP-1,increased |
| R37 | T33 | T32 | ThemeOf | AOXGD,increased |
| R38 | T37 | T35 | ThemeOf | production,promoted |
| R39 | T38 | T35 | CauseOf | stimulating,promoted |
| R40 | T37 | T38 | ThemeOf | production,stimulating |
| R41 | T39 | T38 | ThemeOf | phosphorylation,stimulating |
| R42 | T40 | T39 | ThemeOf | JAK2,phosphorylation |
| R43 | T40 | T38 | ThemeOf | JAK2,stimulating |
| R44 | T43 | T46 | ThemeOf | IL-17,markers |
| R45 | T43 | T50 | ThemeOf | IL-17,increased |
| R46 | T47 | T46 | ThemeOf | Th1,markers |
| R47 | T49 | T46 | ThemeOf | Th17 cells,markers |
| R48 | T46 | T50 | ThemeOf | markers,increased |
| R49 | T47 | T50 | ThemeOf | Th1,increased |
| R50 | T49 | T50 | ThemeOf | Th17 cells,increased |
| R51 | T51 | T54 | ThemeOf | implied,activated |
| R52 | T52 | T51 | ThemeOf | IL6~JAK2/STAT3-TIMP-1 signalling pathway,implied |
| R53 | T52 | T54 | ThemeOf | IL6~JAK2/STAT3-TIMP-1 signalling pathway,activated |
| R54 | T55 | T51 | ThemeOf | AOXGD,implied |
| R55 | T55 | T54 | ThemeOf | AOXGD,activated |
| R56 | T55 | T58 | ThemeOf | AOXGD,involved |
| R57 | T57 | T51 | ThemeOf | Th17 responses,implied |
| R58 | T57 | T54 | ThemeOf | Th17 responses,activated |
| R59 | T57 | T58 | ThemeOf | Th17 responses,involved |
| R60 | T59 | T51 | ThemeOf | AOXGD,implied |
| R61 | T59 | T54 | ThemeOf | AOXGD,activated |
| R62 | T59 | T58 | ThemeOf | AOXGD,involved |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-102 | Sentence | denotes | TIMP-1 Mediates Inflammatory and Immune Response to IL-6 in Adult Orbital Xanthogranulomatous Disease. |
| T2 | 103-111 | Sentence | denotes | Purpose: |
| T3 | 112-326 | Sentence | denotes | To explore the pathogenesis that TIMP-1 mediated in adult orbital xanthogranulomatous disease (AOXGD), a rare type of non-Langerhans histiocytosis that damages the appearance and quality of life of patientsMethods: |
| T4 | 327-666 | Sentence | denotes | We reviewed 22 patients diagnosed with AOXGD based on clinical manifestations and histological analysis, and then investigated the expression of TIMP-1 and IL-6 with q-PCR and IHC in AOXGD tissues and the possible mechanism involved in the induction of TIMP-1 by IL-6.Results: IL-6 and TIMP-1 were significantly increased in AOXGD tissues. |
| T5 | 667-770 | Sentence | denotes | IL-6 promoted TIMP-1 production by M1 macrophages by stimulating the phosphorylation of JAK2 and STAT3. |
| T6 | 771-878 | Sentence | denotes | Moreover, IL-17 and IFN-γ, the classical markers of Th1 and Th17 cells, were increased in AOXGD.Conclusion: |
| T7 | 879-1052 | Sentence | denotes | These data implied that the IL6~JAK2/STAT3-TIMP-1 signalling pathway is activated in AOXGD and that adaptive Th1 and Th17 responses are involved in the development of AOXGD. |
| T1 | 0-102 | Sentence | denotes | TIMP-1 Mediates Inflammatory and Immune Response to IL-6 in Adult Orbital Xanthogranulomatous Disease. |
| T2 | 103-111 | Sentence | denotes | Purpose: |
| T3 | 112-326 | Sentence | denotes | To explore the pathogenesis that TIMP-1 mediated in adult orbital xanthogranulomatous disease (AOXGD), a rare type of non-Langerhans histiocytosis that damages the appearance and quality of life of patientsMethods: |
| T4 | 327-666 | Sentence | denotes | We reviewed 22 patients diagnosed with AOXGD based on clinical manifestations and histological analysis, and then investigated the expression of TIMP-1 and IL-6 with q-PCR and IHC in AOXGD tissues and the possible mechanism involved in the induction of TIMP-1 by IL-6.Results: IL-6 and TIMP-1 were significantly increased in AOXGD tissues. |
| T5 | 667-770 | Sentence | denotes | IL-6 promoted TIMP-1 production by M1 macrophages by stimulating the phosphorylation of JAK2 and STAT3. |
| T6 | 771-878 | Sentence | denotes | Moreover, IL-17 and IFN-γ, the classical markers of Th1 and Th17 cells, were increased in AOXGD.Conclusion: |
| T7 | 879-1052 | Sentence | denotes | These data implied that the IL6~JAK2/STAT3-TIMP-1 signalling pathway is activated in AOXGD and that adaptive Th1 and Th17 responses are involved in the development of AOXGD. |